510(k) K202094
K202094 is an FDA 510(k) premarket notification submitted by Quipu S.R.L for the device "Cardiovascular Suite 4.2.1". The FDA issued a decision of Substantially Equivalent on Jan 11, 2022. The device falls under product code DQK (Computer, Diagnostic, Programmable), a Class II device regulated under 21 CFR 870.1425.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jan 11, 2022
- Date Received
- Jul 28, 2020
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Computer, Diagnostic, Programmable
- Device Class
- Class II
- Regulation Number
- 870.1425
- Review Panel
- CV
- Submission Type
- 510(k)